Oct 04, 2018 7:00 am EDT Heat Biologics’ Pelican Subsidiary Provides Update on its Novel PTX-35 T-Cell Costimulator
Aug 29, 2018 7:00 am EDT Heat Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference in New York City
Aug 14, 2018 7:30 am EDT Heat Biologics Reports Second Quarter 2018 Results and Provides Corporate Update
May 15, 2018 7:00 am EDT Heat Biologics Reports First Quarter 2018 Results and Provides Corporate Update
Apr 18, 2018 7:00 am EDT Heat Biologics Announces Upcoming Milestones Following Positive Interim Phase 2 Results for HS-110
Mar 26, 2018 7:00 am EDT Heat Biologics Reports Positive Data to Further Support the Mechanism of Action for its Proprietary T-Cell Activation Platform